FDA Approves New Anthrax Vaccine for Adults Despite Lack of Publicly Available Information on Testing, Ingredients • Children's Health Defense

fda approves anthrax vaccine cyfendus feature

FDA Approves New Anthrax Vaccine for Adults Despite Lack of Publicly Available Information on Testing, Ingredients

The vaccine, Cyfendus, is approved for use after suspected or confirmed exposure to Bacillus anthracis, also known as anthrax, but must be administered together with other antibacterial drugs.